Recurrence of Drug-Induced Lupus Secondary to Vedolizumab Use in a Patient With Crohn's Disease.
Crohn's disease
IBD
drug-induced lupus
infliximab
vedolizumab
Journal
ACG case reports journal
ISSN: 2326-3253
Titre abrégé: ACG Case Rep J
Pays: United States
ID NLM: 101638398
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
received:
06
05
2023
accepted:
22
12
2023
medline:
26
1
2024
pubmed:
26
1
2024
entrez:
26
1
2024
Statut:
epublish
Résumé
Drug-induced lupus is an autoimmune phenomenon characterized by the development of systemic lupus erythematosus-like clinical features after drug exposure. The entity is a clinical diagnosis. Evaluation consists of recognizing systemic lupus erythematosus-like features, identifying an appropriate causative agent, observing elevations of characteristic autoantibodies, and obtaining positive response with drug discontinuation. Vedolizumab is an anti-α
Identifiants
pubmed: 38274296
doi: 10.14309/crj.0000000000001270
pii: ACGCR-23-0395
pmc: PMC10810571
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e01270Informations de copyright
© 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.